Envestnet Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.7M Sell
153,244
-29,853
-16% -$16.7M 0.02% 653
2026
Q1
$103M Buy
183,097
+3,198
+2% +$2.05M 0.03% 522
2025
Q4
$122M Sell
179,899
-22,022
-11% -$15M 0.04% 442
2025
Q3
$129M Sell
201,921
-28,990
-13% -$17.6M 0.04% 434
2025
Q2
$124M Buy
230,911
+69,082
+43% +$33M 0.04% 432
2025
Q1
$68M Buy
161,829
+12,255
+8% +$5.32M 0.02% 595
2024
Q4
$61.8M Sell
149,574
-43,142
-22% -$18.9M 0.02% 612
2024
Q3
$97.4M Sell
192,716
-23,504
-11% -$11.4M 0.03% 481
2024
Q2
$105M Buy
216,220
+13,532
+7% +$6.79M 0.04% 437
2024
Q1
$109M Sell
202,688
-9,477
-4% -$5.18M 0.04% 422
2023
Q4
$118M Buy
212,165
+687
+0.3% +$323K 0.05% 367
2023
Q3
$92.5M Buy
211,478
+37,278
+21% +$18.6M 0.04% 405
2023
Q2
$87.5M Sell
174,200
-663
-0.4% -$318K 0.04% 374
2023
Q1
$87.4M Buy
174,863
+2,930
+2% +$1.4M 0.04% 358
2022
Q4
$70.1M Buy
171,933
+3,065
+2% +$1.19M 0.04% 389
2022
Q3
$55M Buy
168,868
+10,328
+7% +$3.79M 0.03% 414
2022
Q2
$55.6M Buy
158,540
+9,073
+6% +$3.7M 0.03% 409
2022
Q1
$81.8M Buy
149,467
+9,232
+7% +$4.86M 0.04% 353
2021
Q4
$92.3M Buy
140,235
+3,391
+2% +$2.13M 0.05% 330
2021
Q3
$85.1M Sell
136,844
-10,868
-7% -$7.3M 0.05% 329
2021
Q2
$93.3M Sell
147,712
-9,089
-6% -$5.02M 0.05% 297
2021
Q1
$76.7M Buy
156,801
+40,900
+35% +$20.5M 0.05% 304
2020
Q4
$57.9M Buy
115,901
+18,557
+19% +$8.3M 0.04% 309
2020
Q3
$38.3M Buy
97,344
+11,487
+13% +$4.25M 0.03% 366
2020
Q2
$28.3M Buy
85,857
+32,259
+60% +$9.34M 0.03% 419
2020
Q1
$13M Sell
53,598
-14,805
-22% -$3.86M 0.02% 586
2019
Q4
$17.9M Sell
68,403
-21,635
-24% -$5.7M 0.02% 566
2019
Q3
$24.5M Buy
90,038
+46,530
+107% +$12.9M 0.03% 431
2019
Q2
$12M Sell
43,508
-15,340
-26% -$3.78M 0.02% 652
2019
Q1
$13.2M Buy
58,848
+6,129
+12% +$1.27M 0.02% 588
2018
Q4
$9.81M Buy
52,719
+23,169
+78% +$4.75M 0.02% 615
2018
Q3
$7.38M Sell
29,550
-97
-0.3% -$23.5K 0.01% 358
2018
Q2
$6.46M Buy
29,647
+22,278
+302% +$4.59M 0.01% 423
2018
Q1
$1.42M Sell
7,369
-19,413
-72% -$3.58M ﹤0.01% 828
2017
Q4
$4.19M Buy
26,782
+1,487
+6% +$234K 0.01% 653
2017
Q3
$3.93M Sell
25,295
-900
-3% -$142K 0.01% 646
2017
Q2
$4.23M Sell
26,195
-8,001
-23% -$1.3M 0.01% 627
2017
Q1
$5.29M Sell
34,196
-220
-0.6% -$30.3K 0.02% 558
2016
Q4
$4.03M Buy
34,416
+3,331
+11% +$380K 0.01% 627
2016
Q3
$3.5M Sell
31,085
-24,101
-44% -$2.54M 0.01% 723
2016
Q2
$5.13M Buy
55,186
+5,856
+12% +$503K 0.02% 610
2016
Q1
$3.86M Buy
49,330
+2,045
+4% +$147K 0.02% 691
2015
Q4
$3.45M Buy
47,285
+5,703
+14% +$407K 0.02% 721
2015
Q3
$3.09M Buy
41,582
+11,801
+40% +$845K 0.02% 755
2015
Q2
$1.91M Sell
29,781
-255
-0.8% -$17.7K 0.01% 1075
2015
Q1
$2.32M Buy
30,036
+29,338
+4,203% +$2.28M 0.01% 900
2014
Q4
$52K Buy
+698
New +$48.9K ﹤0.01% 1404
2014
Q2
Sell
-52
Closed -$3K 2754
2014
Q1
$3K Buy
+52
New +$3.1K ﹤0.01% 2212
2013
Q4
Sell
-1,126
Closed -$56K 2498
2013
Q3
$56K Buy
1,126
+188
+20% +$9.04K ﹤0.01% 1169
2013
Q2
$42K Buy
+938
New +$41K ﹤0.01% 1212

Other funds holding IDXX

Envestnet Asset Management's IDXX Position: Q2 2026 in Review

Envestnet Asset Management reduced its Idexx Laboratories (IDXX) stake by 16% in Q2 2026, selling an estimated $16.7M and leaving 153,244 shares worth $80.7M. The position accounts for 0.02% of the portfolio, ranked #653.

Envestnet Asset Management first reported a position in IDXX in Q2 2013 and has held it in 50 quarters since. The position peaked at $129M in Q3 2025. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Envestnet Asset Management held 153,244 shares of Idexx Laboratories worth $80.7M as of Q2 2026.
  • Envestnet Asset Management sold 29,853 Idexx Laboratories shares in Q2 2026, an estimated $16.7M.
  • Idexx Laboratories made up 0.02% of Envestnet Asset Management's portfolio in Q2 2026, its #653 holding.
  • Envestnet Asset Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 50 quarters since.
  • Envestnet Asset Management's Idexx Laboratories position peaked at $129M in Q3 2025.
  • 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.